论文信息 - Meeting report on protein particles and immunogenicity of therapeutic proteins: filling in the gaps in risk evaluation and mitigation. - 字舞流文

Meeting report on protein particles and immunogenicity of therapeutic proteins: filling in the gaps in risk evaluation and mitigation.

A. Mire-Sluis | T. Nikolai | B. Cherney | J. Šimák | J. Ragheb | Stacey Ma | E. Marszal | Jeanne M. Novak | J. Carpenter | Anthony Lubinecki

[1] Huub Schellekens,et al. Antibody response to aggregated human interferon alpha2b in wild-type and transgenic immune tolerant mice depends on type and level of aggregation. , 2006, Journal of Pharmacy and Science.

[2] Huub Schellekens,et al. Structural Characterization and Immunogenicity in Wild-Type and Immune Tolerant Mice of Degraded Recombinant Human Interferon Alpha2b , 2005, Pharmaceutical Research.

[3] R. Zinkernagel,et al. Neutralizing antiviral B cell responses. , 1997, Annual review of immunology.

[4] H. Dintzis,et al. The immunogenicity of soluble haptenated polymers is determined by molecular mass and hapten valence. , 1989, Journal of immunology.

[5] W V Moore,et al. Role of aggregated human growth hormone (hGH) in development of antibodies to hGH. , 1980, The Journal of clinical endocrinology and metabolism.

[6] J. Ring,et al. Anaphylactoid reactions to infusions of plasma protein and human serum albumin Role of aggregated proteins and of stabilizers added during production , 1979, Clinical allergy.

[7] S. J. Taub. Adverse reactions following administration of human gamma globulin. , 1969, Eye, ear, nose & throat monthly.